1 Study Coverage 1.1 Anti-inflammatory Biologics Product Introduction 1.2 Market by Type 1.2.1 Global Anti-inflammatory Biologics Market Size Growth Rate by Type 1.2.2 Synthetic Type 1.2.3 Biological Type 1.3 Market by Application 1.3.1 Global Anti-inflammatory Biologics Market Size Growth Rate by Application 1.3.2 Arthritis 1.3.3 Respiratory Diseases 1.3.4 Dermatology 1.3.5 Gastroenterology 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Anti-inflammatory Biologics Market Size, Estimates and Forecasts 2.1.1 Global Anti-inflammatory Biologics Revenue 2016-2027 2.1.2 Global Anti-inflammatory Biologics Sales 2016-2027 2.2 Global Anti-inflammatory Biologics, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Anti-inflammatory Biologics Historical Market Size by Region (2016-2021) 2.3.1 Global Anti-inflammatory Biologics Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Anti-inflammatory Biologics Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Anti-inflammatory Biologics Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Anti-inflammatory Biologics Sales Forecast by Region (2022-2027) 2.4.2 Global Anti-inflammatory Biologics Revenue Forecast by Region (2022-2027) 3 Global Anti-inflammatory Biologics Competitor Landscape by Players 3.1 Global Top Anti-inflammatory Biologics Manufacturers by Sales 3.1.1 Global Anti-inflammatory Biologics Sales by Manufacturer (2016-2021) 3.1.2 Global Anti-inflammatory Biologics Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Anti-inflammatory Biologics Manufacturers by Revenue 3.2.1 Key Anti-inflammatory Biologics Manufacturers Covered: Ranking by Revenue 3.2.2 Global Anti-inflammatory Biologics Revenue by Manufacturers (2016-2021) 3.2.3 Global Anti-inflammatory Biologics Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Anti-inflammatory Biologics Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Anti-inflammatory Biologics Revenue in 2020 3.2.6 Global Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Anti-inflammatory Biologics Price by Manufacturers 3.4 Global Anti-inflammatory Biologics Manufacturing Base Distribution, Product Types 3.4.1 Anti-inflammatory Biologics Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Anti-inflammatory Biologics Product Type 3.4.3 Date of International Manufacturers Enter into Anti-inflammatory Biologics Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Anti-inflammatory Biologics Market Size by Type (2016-2021) 4.1.1 Global Anti-inflammatory Biologics Sales by Type (2016-2021) 4.1.2 Global Anti-inflammatory Biologics Revenue by Type (2016-2021) 4.1.3 Anti-inflammatory Biologics Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Anti-inflammatory Biologics Market Size Forecast by Type (2022-2027) 4.2.1 Global Anti-inflammatory Biologics Sales Forecast by Type (2022-2027) 4.2.2 Global Anti-inflammatory Biologics Revenue Forecast by Type (2022-2027) 4.2.3 Anti-inflammatory Biologics Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Anti-inflammatory Biologics Market Size by Application (2016-2021) 5.1.1 Global Anti-inflammatory Biologics Sales by Application (2016-2021) 5.1.2 Global Anti-inflammatory Biologics Revenue by Application (2016-2021) 5.1.3 Anti-inflammatory Biologics Price by Application (2016-2021) 5.2 Anti-inflammatory Biologics Market Size Forecast by Application (2022-2027) 5.2.1 Global Anti-inflammatory Biologics Sales Forecast by Application (2022-2027) 5.2.2 Global Anti-inflammatory Biologics Revenue Forecast by Application (2022-2027) 5.2.3 Global Anti-inflammatory Biologics Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Anti-inflammatory Biologics Market Size YoY Growth 2016-2027 6.1.1 Japan Anti-inflammatory Biologics Sales YoY Growth 2016-2027 6.1.2 Japan Anti-inflammatory Biologics Revenue YoY Growth 2016-2027 6.1.3 Japan Anti-inflammatory Biologics Market Share in Global Market 2016-2027 6.2 Japan Anti-inflammatory Biologics Market Size by Players (International and Local Players) 6.2.1 Japan Top Anti-inflammatory Biologics Players by Sales (2016-2021) 6.2.2 Japan Top Anti-inflammatory Biologics Players by Revenue (2016-2021) 6.3 Japan Anti-inflammatory Biologics Historic Market Review by Type (2016-2021) 6.3.1 Japan Anti-inflammatory Biologics Sales Market Share by Type (2016-2021) 6.3.2 Japan Anti-inflammatory Biologics Revenue Market Share by Type (2016-2021) 6.3.3 Japan Anti-inflammatory Biologics Price by Type (2016-2021) 6.4 Japan Anti-inflammatory Biologics Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Anti-inflammatory Biologics Sales Forecast by Type (2022-2027) 6.4.2 Japan Anti-inflammatory Biologics Revenue Forecast by Type (2022-2027) 6.4.3 Japan Anti-inflammatory Biologics Price Forecast by Type (2022-2027) 6.5 Japan Anti-inflammatory Biologics Historic Market Review by Application (2016-2021) 6.5.1 Japan Anti-inflammatory Biologics Sales Market Share by Application (2016-2021) 6.5.2 Japan Anti-inflammatory Biologics Revenue Market Share by Application (2016-2021) 6.5.3 Japan Anti-inflammatory Biologics Price by Application (2016-2021) 6.6 Japan Anti-inflammatory Biologics Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Anti-inflammatory Biologics Sales Forecast by Application (2022-2027) 6.6.2 Japan Anti-inflammatory Biologics Revenue Forecast by Application (2022-2027) 6.6.3 Japan Anti-inflammatory Biologics Price Forecast by Application (2022-2027) 7 North America 7.1 North America Anti-inflammatory Biologics Market Size YoY Growth 2016-2027 7.2 North America Anti-inflammatory Biologics Market Facts & Figures by Country 7.2.1 North America Anti-inflammatory Biologics Sales by Country (2016-2021) 7.2.2 North America Anti-inflammatory Biologics Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Anti-inflammatory Biologics Market Size YoY Growth 2016-2027 8.2 Asia Pacific Anti-inflammatory Biologics Market Facts & Figures by Region 8.2.1 Asia Pacific Anti-inflammatory Biologics Sales by Region (2016-2021) 8.2.2 Asia Pacific Anti-inflammatory Biologics Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Anti-inflammatory Biologics Market Size YoY Growth 2016-2027 9.2 Europe Anti-inflammatory Biologics Market Facts & Figures by Country 9.2.1 Europe Anti-inflammatory Biologics Sales by Country (2016-2021) 9.2.2 Europe Anti-inflammatory Biologics Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Anti-inflammatory Biologics Market Size YoY Growth 2016-2027 10.2 Latin America Anti-inflammatory Biologics Market Facts & Figures by Country 10.2.1 Latin America Anti-inflammatory Biologics Sales by Country (2016-2021) 10.2.2 Latin America Anti-inflammatory Biologics Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Anti-inflammatory Biologics Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Anti-inflammatory Biologics Market Facts & Figures by Country 11.2.1 Middle East and Africa Anti-inflammatory Biologics Sales by Country (2016-2021) 11.2.2 Middle East and Africa Anti-inflammatory Biologics Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 AbbVie 12.1.1 AbbVie Corporation Information 12.1.2 AbbVie Description and Business Overview 12.1.3 AbbVie Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021) 12.1.4 AbbVie Anti-inflammatory Biologics Products Offered 12.1.5 AbbVie Recent Development 12.2 Johnson & Johnson 12.2.1 Johnson & Johnson Corporation Information 12.2.2 Johnson & Johnson Description and Business Overview 12.2.3 Johnson & Johnson Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Johnson & Johnson Anti-inflammatory Biologics Products Offered 12.2.5 Johnson & Johnson Recent Development 12.3 Amgen Inc 12.3.1 Amgen Inc Corporation Information 12.3.2 Amgen Inc Description and Business Overview 12.3.3 Amgen Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Amgen Inc Anti-inflammatory Biologics Products Offered 12.3.5 Amgen Inc Recent Development 12.4 AstraZeneca PLC 12.4.1 AstraZeneca PLC Corporation Information 12.4.2 AstraZeneca PLC Description and Business Overview 12.4.3 AstraZeneca PLC Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021) 12.4.4 AstraZeneca PLC Anti-inflammatory Biologics Products Offered 12.4.5 AstraZeneca PLC Recent Development 12.5 Pfizer, Inc 12.5.1 Pfizer, Inc Corporation Information 12.5.2 Pfizer, Inc Description and Business Overview 12.5.3 Pfizer, Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Pfizer, Inc Anti-inflammatory Biologics Products Offered 12.5.5 Pfizer, Inc Recent Development 12.6 Novartis 12.6.1 Novartis Corporation Information 12.6.2 Novartis Description and Business Overview 12.6.3 Novartis Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Novartis Anti-inflammatory Biologics Products Offered 12.6.5 Novartis Recent Development 12.7 Roche 12.7.1 Roche Corporation Information 12.7.2 Roche Description and Business Overview 12.7.3 Roche Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Roche Anti-inflammatory Biologics Products Offered 12.7.5 Roche Recent Development 12.8 Sun Pharmaceutical Industries Ltd 12.8.1 Sun Pharmaceutical Industries Ltd Corporation Information 12.8.2 Sun Pharmaceutical Industries Ltd Description and Business Overview 12.8.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Products Offered 12.8.5 Sun Pharmaceutical Industries Ltd Recent Development 12.9 Sanofi 12.9.1 Sanofi Corporation Information 12.9.2 Sanofi Description and Business Overview 12.9.3 Sanofi Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Sanofi Anti-inflammatory Biologics Products Offered 12.9.5 Sanofi Recent Development 12.10 GlaxoSmithKline 12.10.1 GlaxoSmithKline Corporation Information 12.10.2 GlaxoSmithKline Description and Business Overview 12.10.3 GlaxoSmithKline Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021) 12.10.4 GlaxoSmithKline Anti-inflammatory Biologics Products Offered 12.10.5 GlaxoSmithKline Recent Development 12.11 AbbVie 12.11.1 AbbVie Corporation Information 12.11.2 AbbVie Description and Business Overview 12.11.3 AbbVie Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021) 12.11.4 AbbVie Anti-inflammatory Biologics Products Offered 12.11.5 AbbVie Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Anti-inflammatory Biologics Industry Trends 13.2 Anti-inflammatory Biologics Market Drivers 13.3 Anti-inflammatory Biologics Market Challenges 13.4 Anti-inflammatory Biologics Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Anti-inflammatory Biologics Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Anti-inflammatory Biologics Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Synthetic Type Table 3. Major Manufacturers of Biological Type Table 4. Global Anti-inflammatory Biologics Market Size Growth Rate by Application (2021-2027) & (K MT) Table 5. Global Anti-inflammatory Biologics Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Anti-inflammatory Biologics Sales by Regions (2016-2021) & (K MT) Table 7. Global Anti-inflammatory Biologics Sales Market Share by Regions (2016-2021) Table 8. Global Anti-inflammatory Biologics Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Anti-inflammatory Biologics Sales Forecast by Region (2022-2027) & (K MT) Table 10. Global Anti-inflammatory Biologics Sales Market Share Forecast by Region (2022-2027) Table 11. Global Anti-inflammatory Biologics Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Anti-inflammatory Biologics Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Anti-inflammatory Biologics Sales by Manufacturers (2016-2021) (K MT) Table 14. Global Anti-inflammatory Biologics Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Anti-inflammatory Biologics Manufacturers by Revenue (US$ Million) in 2020 Table 16. Anti-inflammatory Biologics Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Anti-inflammatory Biologics Revenue Share by Manufacturers (2016-2021) Table 18. Global Anti-inflammatory Biologics Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Anti-inflammatory Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Biologics as of 2020) Table 20. Key Manufacturers Anti-inflammatory Biologics Price (2016-2021) (USD/MT) Table 21. Anti-inflammatory Biologics Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Anti-inflammatory Biologics Product Type Table 23. Date of International Manufacturers Enter into Anti-inflammatory Biologics Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Anti-inflammatory Biologics Sales by Type (2016-2021) (K MT) Table 26. Global Anti-inflammatory Biologics Sales Share by Type (2016-2021) Table 27. Global Anti-inflammatory Biologics Revenue by Type (2016-2021) (US$ Million) Table 28. Global Anti-inflammatory Biologics Revenue Share by Type (2016-2021) Table 29. Anti-inflammatory Biologics Average Selling Price (ASP) by Type (2016-2021) & (USD/MT) Table 30. Global Anti-inflammatory Biologics Sales Forecast by Type (2022-2027) & (K MT) Table 31. Global Anti-inflammatory Biologics Sales Market Share Forecast by Type (2022-2027) Table 32. Global Anti-inflammatory Biologics Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Anti-inflammatory Biologics Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Anti-inflammatory Biologics Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT) Table 35. Global Anti-inflammatory Biologics Sales by Application (2016-2021) (K MT) Table 36. Global Anti-inflammatory Biologics Sales Share by Application (2016-2021) Table 37. Global Anti-inflammatory Biologics Revenue by Application (2016-2021) (US$ Million) Table 38. Global Anti-inflammatory Biologics Revenue Share by Application (2016-2021) Table 39. Anti-inflammatory Biologics Average Selling Price (ASP) by Application (2016-2021) & (USD/MT) Table 40. Global Anti-inflammatory Biologics Sales Forecast by Application (2022-2027) & (K MT) Table 41. Global Anti-inflammatory Biologics Sales Market Share Forecast by Application (2022-2027) Table 42. Global Anti-inflammatory Biologics Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Anti-inflammatory Biologics Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Anti-inflammatory Biologics Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT) Table 45. Japan Anti-inflammatory Biologics Sales (K MT) of Key Companies (2016-2021) Table 46. Japan Anti-inflammatory Biologics Sales Share by Company (2016-2021) Table 47. Japan Anti-inflammatory Biologics Revenue (US$ Million) by Company (2016-2021) Table 48. Japan Anti-inflammatory Biologics Revenue Share by Company (2016-2021) Table 49. Japan Anti-inflammatory Biologics Sales (K MT) by Type (2016-2021) Table 50. Japan Anti-inflammatory Biologics Sales Share by Type (2016-2021) Table 51. Japan Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. Japan Anti-inflammatory Biologics Price (USD/MT) by Type (2016-2021) Table 53. Japan Anti-inflammatory Biologics Sales (K MT) by Type (2022-2027) Table 54. Japan Anti-inflammatory Biologics Sales Share by Type (2022-2027) Table 55. Japan Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. Japan Anti-inflammatory Biologics Revenue Share by Type (2022-2027) Table 57. Japan Anti-inflammatory Biologics Price (USD/MT) by Type (2022-2027) Table 58. Japan Anti-inflammatory Biologics Sales (K MT) by Application (2016-2021) Table 59. Japan Anti-inflammatory Biologics Sales Share by Application (2016-2021) Table 60. Japan Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. Japan Anti-inflammatory Biologics Price (USD/MT) by Application (2016-2021) Table 62. Japan Anti-inflammatory Biologics Sales (K MT) by Application (2022-2027) Table 63. Japan Anti-inflammatory Biologics Sales Share by Application (2022-2027) Table 64. Japan Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. Japan Anti-inflammatory Biologics Revenue Share by Application (2022-2027) Table 66. Japan Anti-inflammatory Biologics Price (USD/MT) by Application (2022-2027) Table 67. North America Anti-inflammatory Biologics Sales by Country (2016-2021) & (K MT) Table 68. North America Anti-inflammatory Biologics Sales Market Share by Country (2016-2021) Table 69. North America Anti-inflammatory Biologics Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Anti-inflammatory Biologics Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Anti-inflammatory Biologics Sales by Region (2016-2021) & (K MT) Table 72. Asia Pacific Anti-inflammatory Biologics Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Anti-inflammatory Biologics Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Anti-inflammatory Biologics Revenue Market Share by Region (2016-2021) Table 75. Europe Anti-inflammatory Biologics Sales by Country (2016-2021) & (K MT) Table 76. Europe Anti-inflammatory Biologics Sales Market Share by Country (2016-2021) Table 77. Europe Anti-inflammatory Biologics Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Anti-inflammatory Biologics Revenue Market Share by Country (2016-2021) Table 79. Latin America Anti-inflammatory Biologics Sales by Country (2016-2021) & (K MT) Table 80. Latin America Anti-inflammatory Biologics Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Anti-inflammatory Biologics Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Anti-inflammatory Biologics Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Anti-inflammatory Biologics Sales by Country (2016-2021) & (K MT) Table 84. Middle East and Africa Anti-inflammatory Biologics Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Anti-inflammatory Biologics Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Anti-inflammatory Biologics Revenue Market Share by Country (2016-2021) Table 87. AbbVie Corporation Information Table 88. AbbVie Description and Business Overview Table 89. AbbVie Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 90. AbbVie Anti-inflammatory Biologics Product Table 91. AbbVie Recent Development Table 92. Johnson & Johnson Corporation Information Table 93. Johnson & Johnson Description and Business Overview Table 94. Johnson & Johnson Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 95. Johnson & Johnson Product Table 96. Johnson & Johnson Recent Development Table 97. Amgen Inc Corporation Information Table 98. Amgen Inc Description and Business Overview Table 99. Amgen Inc Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 100. Amgen Inc Product Table 101. Amgen Inc Recent Development Table 102. AstraZeneca PLC Corporation Information Table 103. AstraZeneca PLC Description and Business Overview Table 104. AstraZeneca PLC Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 105. AstraZeneca PLC Product Table 106. AstraZeneca PLC Recent Development Table 107. Pfizer, Inc Corporation Information Table 108. Pfizer, Inc Description and Business Overview Table 109. Pfizer, Inc Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 110. Pfizer, Inc Product Table 111. Pfizer, Inc Recent Development Table 112. Novartis Corporation Information Table 113. Novartis Description and Business Overview Table 114. Novartis Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 115. Novartis Product Table 116. Novartis Recent Development Table 117. Roche Corporation Information Table 118. Roche Description and Business Overview Table 119. Roche Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 120. Roche Product Table 121. Roche Recent Development Table 122. Sun Pharmaceutical Industries Ltd Corporation Information Table 123. Sun Pharmaceutical Industries Ltd Description and Business Overview Table 124. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 125. Sun Pharmaceutical Industries Ltd Product Table 126. Sun Pharmaceutical Industries Ltd Recent Development Table 127. Sanofi Corporation Information Table 128. Sanofi Description and Business Overview Table 129. Sanofi Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 130. Sanofi Product Table 131. Sanofi Recent Development Table 132. GlaxoSmithKline Corporation Information Table 133. GlaxoSmithKline Description and Business Overview Table 134. GlaxoSmithKline Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 135. GlaxoSmithKline Product Table 136. GlaxoSmithKline Recent Development Table 137. Anti-inflammatory Biologics Market Trends Table 138. Anti-inflammatory Biologics Market Drivers Table 139. Anti-inflammatory Biologics Market Challenges Table 140. Anti-inflammatory Biologics Market Restraints Table 141. Anti-inflammatory Biologics Customers List Table 142. Anti-inflammatory Biologics Distributors List Table 143. Research Programs/Design for This Report Table 144. Key Data Information from Secondary Sources Table 145. Key Data Information from Primary Sources List of Figures Figure 1. Anti-inflammatory Biologics Product Picture Figure 2. Global Anti-inflammatory Biologics Sales Market Share by Type in 2020 & 2027 Figure 3. Synthetic Type Product Picture Figure 4. Biological Type Product Picture Figure 5. Global Anti-inflammatory Biologics Sales Market Share by Application in 2020 & 2027 Figure 6. Arthritis Figure 7. Respiratory Diseases Figure 8. Dermatology Figure 9. Gastroenterology Figure 10. Others Figure 11. Anti-inflammatory Biologics Report Years Considered Figure 12. Global Anti-inflammatory Biologics Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Anti-inflammatory Biologics Market Size 2016-2027 (US$ Million) Figure 14. Global Anti-inflammatory Biologics Sales 2016-2027 (K MT) Figure 15. Global Anti-inflammatory Biologics Market Size Market Share by Region: 2021 Versus 2027 Figure 16. Global Anti-inflammatory Biologics Sales Market Share by Region (2016-2021) Figure 17. Global Anti-inflammatory Biologics Sales Market Share by Region in 2020 Figure 18. Global Anti-inflammatory Biologics Revenue Market Share by Region (2016-2021) Figure 19. Global Anti-inflammatory Biologics Revenue Market Share by Region in 2020 Figure 20. Global Anti-inflammatory Biologics Sales Share by Manufacturer in 2020 Figure 21. The Top 10 and 5 Players Market Share by Anti-inflammatory Biologics Revenue in 2020 Figure 22. Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Anti-inflammatory Biologics Sales Market Share by Type (2016-2021) Figure 24. Global Anti-inflammatory Biologics Sales Market Share by Type in 2020 Figure 25. Global Anti-inflammatory Biologics Revenue Market Share by Type (2016-2021) Figure 26. Global Anti-inflammatory Biologics Revenue Market Share by Type in 2020 Figure 27. Global Anti-inflammatory Biologics Sales Market Share by Application (2016-2021) Figure 28. Global Anti-inflammatory Biologics Sales Market Share by Application in 2020 Figure 29. Global Anti-inflammatory Biologics Revenue Market Share by Application (2016-2021) Figure 30. Global Anti-inflammatory Biologics Revenue Market Share by Application in 2020 Figure 31. Japan Anti-inflammatory Biologics Sales Growth Rate 2016-2027 (K MT) Figure 32. Japan Anti-inflammatory Biologics Revenue Growth Rate 2016-2027 (US$ Million) Figure 33. Japan Anti-inflammatory Biologics Market Share in Global Market 2016-2027 Figure 34. Japan 5 and 10 Largest Anti-inflammatory Biologics Players Market Share by Revenue in Anti-inflammatory Biologics in 2020 Figure 35. Japan Anti-inflammatory Biologics Revenue Share by Type (2016-2021) Figure 36. Japan Anti-inflammatory Biologics Revenue Growth Rate by Type in 2016 & 2020 Figure 37. Japan Anti-inflammatory Biologics Revenue Share by Application (2016-2021) Figure 38. Japan Anti-inflammatory Biologics Revenue Growth Rate by Application in 2016 & 2020 Figure 39. North America Anti-inflammatory Biologics Sales Growth Rate 2016-2021 (K MT) Figure 40. North America Anti-inflammatory Biologics Revenue Growth Rate 2016-2021 (US$ Million) Figure 41. North America Anti-inflammatory Biologics Sales Market Share by Country in 2020 Figure 42. North America Anti-inflammatory Biologics Revenue Market Share by Country in 2020 Figure 43. U.S. Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 44. U.S. Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Canada Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 46. Canada Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Europe Anti-inflammatory Biologics Sales Growth Rate 2016-2021 (K MT) Figure 48. Europe Anti-inflammatory Biologics Revenue Growth Rate 2016-2021 (US$ Million) Figure 49. Europe Anti-inflammatory Biologics Sales Market Share by Country in 2020 Figure 50. Europe Anti-inflammatory Biologics Revenue Market Share by Country in 2020 Figure 51. Germany Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 52. Germany Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. France Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 54. France Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. U.K. Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 56. U.K. Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Italy Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 58. Italy Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Russia Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 60. Russia Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Asia Pacific Anti-inflammatory Biologics Sales Growth Rate 2016-2021 (K MT) Figure 62. Asia Pacific Anti-inflammatory Biologics Revenue Growth Rate 2016-2021 (US$ Million) Figure 63. Asia Pacific Anti-inflammatory Biologics Sales Market Share by Region in 2020 Figure 64. Asia Pacific Anti-inflammatory Biologics Revenue Market Share by Region in 2020 Figure 65. China Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 66. China Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Japan Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 68. Japan Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. South Korea Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 70. South Korea Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. India Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 72. India Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Australia Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 74. Australia Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Taiwan Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 76. Taiwan Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Indonesia Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 78. Indonesia Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Thailand Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 80. Thailand Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Malaysia Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 82. Malaysia Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Philippines Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 84. Philippines Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Vietnam Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 86. Vietnam Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Latin America Anti-inflammatory Biologics Sales Growth Rate 2016-2021 (K MT) Figure 88. Latin America Anti-inflammatory Biologics Revenue Growth Rate 2016-2021 (US$ Million) Figure 89. Latin America Anti-inflammatory Biologics Sales Market Share by Country in 2020 Figure 90. Latin America Anti-inflammatory Biologics Revenue Market Share by Country in 2020 Figure 91. Mexico Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 92. Mexico Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Brazil Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 94. Brazil Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Argentina Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 96. Argentina Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Middle East and Africa Anti-inflammatory Biologics Sales Growth Rate 2016-2021 (K MT) Figure 98. Middle East and Africa Anti-inflammatory Biologics Revenue Growth Rate 2016-2021 (US$ Million) Figure 99. Middle East and Africa Anti-inflammatory Biologics Sales Market Share by Country in 2020 Figure 100. Middle East and Africa Anti-inflammatory Biologics Revenue Market Share by Country in 2020 Figure 101. Turkey Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 102. Turkey Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Saudi Arabia Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 104. Saudi Arabia Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. U.A.E Anti-inflammatory Biologics Sales Growth Rate (2016-2021) (K MT) Figure 106. U.A.E Anti-inflammatory Biologics Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. Anti-inflammatory Biologics Value Chain Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

AbbVie Johnson & Johnson Amgen Inc AstraZeneca PLC Pfizer, Inc Novartis Roche Sun Pharmaceutical Industries Ltd Sanofi GlaxoSmithKline